16 withdrawn. 16 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 16 | Withdrawn 16 |
Follow Respiratory Hypersensitivity: new trials by email Literature Review of Respiratory Hypersensitivity trials Research Report on Respiratory Hypersensitivity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mechanisms for Dyspnea on Exertion in Children With Obesity and Asthma: Distinct Physiological Phenotypes Control, Albuterol - Asthma in Children, Dyspnea; Asthmatic | Phase 4 | Withdrawn | Ohio State University | 2023-07-01 | 2023-11-07 | |
| Triple vs High Dose Inhaled CORticosteroids To compare in both treatment arms the percentage of patients controlled at week 52. - Asthma | Phase 4 | Withdrawn | Galaxia Empírica | 2023-06-01 | 2025-09-04 | |
| Allergic Rhinitis Combination Pharmacotherapy Efficacy Study Fluticasone Propionate, Azelastine hydrochloride and fluticasone propionate, Rupatadine - Allergic Rhinitis | Phase 4 | Withdrawn | St. Paul's Sinus Centre | 2020-12-15 | 2023-10-31 | |
| Benralizumab in the Treatment of Patients With Severe Asthma With ABPA Fasenra, 30 Mg/mL Subcutaneous Solution - ABPA, Severe Asthma | Phase 4 | Withdrawn | Baylor Research Institute | 2019-12-23 | 2022-02-01 | |
| The Efficacy of Fluticasone Furoate/Vilanterol Versus (vs) Fluticasone Furoate on Asthma Fluticasone Furoate/Vilanterol, Fluticasone Furoate, Salbutamol/Albuterol - Asthma | Phase 4 | Withdrawn | GlaxoSmithKline | 2018-03-07 | 2018-01-29 | |
| Combined Glucocorticoid Adrenergic Therapy For Wheezy Preschool Children Beclomethasone, Beclomethasone and Salbutamol, Placebo - Wheeze | Phase 4 | Withdrawn | University of Calgary | 2016-04-01 | 2016-11-15 | |
| Azelastine Fluticasone Combination vs. Fluticasone Azelastine , fluticasone, Fluticasone propionate - Allergic Rhinitis | Phase 4 | Withdrawn | University of Dundee | 2010-08-01 | 2012-06-12 | |
| Correct Use of Sequential Formoterol and Budesonide Inhaler Capsule Treatment Via Aerolizer and Patient Satisfaction in Asthmatics Foradil Combi (Formoterol-budesonide) - Asthma | Phase 4 | Withdrawn | Novartis Pharmaceuticals | 2010-06-01 | 2017-04-20 | |
| A Pilot Investigation of Ciclesonide When Administered as a Hypotonic Versus an Isotonic Formulation of Ciclesonide Nasal Spray placebo, isotonic ciclesonide, hypotonic ciclesonide - Allergic Rhinitis | Phase 4 | Withdrawn | University of Chicago | 2009-02-01 | 2013-06-07 | |
| Peak Bronchoprotection Conferred by Levosalbutamol and Racemic Salbutamol levosalbutamol, racemic salbutamol, placebo - Asthma | Phase 4 | Withdrawn | University of Dundee | 2009-01-01 | 2012-06-12 | |
| Inhaled Corticosteroids on Airway Smooth Muscle in Asthma budesonide - Asthma | Phase 4 | Withdrawn | Imperial College London | 2008-04-01 | 2019-09-13 | |
| No Resistance After Long Term Treatment SERETIDE FLIXOTIDE and SERETIDE - Asthma | Phase 4 | Withdrawn | GlaxoSmithKline | 2007-12-01 | 2015-04-17 | |
| Tiotropium for Smoking Asthmatics Study tiotropium, long acting beta agonist - Asthma | Phase 4 | Withdrawn | University of Alberta | 2007-11-01 | 2016-05-26 | |
| Pulmicort Respules on Relapse Rates After Treatment in the ED pulmicort respules - Asthma | Phase 4 | Withdrawn | Phoenix Children's Hospital | 2007-10-01 | 2026-01-23 | |
| Preventing Tolerance to Oxymetazoline in Allergic Rhinitis oxymetazoline-fluticasone propionate, Oxymetazoline - Allergic Rhinitis, Tachyphylaxis | Phase 4 | Withdrawn | Brian J Lipworth | 2016-10-25 | ||
| An Allergen BioCube (ABC) Study Evaluating the Onset of Action of Fluticasone Furoate Nasal Spray and Olopatadine Nasal Spray Compared to Placebo Fluticasone Furoate Nasal Spray, Olopatadine Nasal Spray, Saline Nasal Spray - Allergic Rhinitis | Phase 4 | Withdrawn | ORA, Inc. | 2012-02-22 |
Asthma (11) · Rhinitis, Allergic (5) · Dyspnea (2) · Respiratory Sounds (2) · Aspergillosis, Allergic Bronchopulmonary (1) · Cough (1) · Emergencies (1) · Motor Activity (1) · Pediatric Obesity (1) · Pulmonary Disease, Chronic Obstructive (1) · Smoking (1)
Hypersensitivity (16) · Hypersensitivity, Immediate (16) · Immune System Diseases (16) · Respiratory Tract Diseases (16) · Bronchial Diseases (11) · Lung Diseases (11) · Lung Diseases, Obstructive (11) · Nose Diseases (5) · Otorhinolaryngologic Diseases (5) · Pathological Conditions, Signs and Symptoms (5) · Rhinitis (5) · Signs and Symptoms (3) · Signs and Symptoms, Respiratory (3) · Behavior (2)
Albuterol (4) · Fluticasone (3) · Budesonide (2) · azelastine (2) · Beclomethasone (1) · Fluticasone-Salmeterol Drug Combination (1) · Formoterol Fumarate (1) · Metered Dose Inhalers (1) · Oxymetazoline (1) · Salmeterol Xinafoate (1) · Tiotropium Bromide (1) · benralizumab (1) · fluticasone furoate (1) · rupatadine (1) · vilanterol (1)
GlaxoSmithKline (2) · University of Dundee (2) · Baylor Research Institute (1) · Brian J Lipworth (1) · Galaxia Empírica (1) · Imperial College London (1) · Novartis Pharmaceuticals (1) · ORA, Inc. (1) · Ohio State University (1) · Phoenix Children's Hospital (1) · St. Paul's Sinus Centre (1) · University of Alberta (1) · University of Calgary (1) · University of Chicago (1)
United Kingdom (4) · United States (4) · Canada (2) · Netherlands (1) · Spain (1) · Turkey (Türkiye) (1)
Brian Lipworth, MD, FRCP (2) · Brian J Lipworth, MBchB (1) · Darcy Marciniuk, MD (1) · Dharini M Bhammar, MBBS, PhD (1) · Dilini Vethanayagam, MD (1) · H. J. Crampton, MD (1) · Harissios Vliagoftis, MD (1) · Irvin Mayers, MD, FRCPC (1) · Karine L Clearie, MBBS, MRCP (1) · Katherine Mandeville, MD (1) · Kian F Chung, MBBS FRCP MD DSc (1) · Robert B Bulloch, MD (1)